Ebola drug stocks soar
The first confirmed case of Ebola in the U.S. drove stocks of Ebola drug makers higher, but airline stocks fell on concerns it could scare travelers. Fred Katayama reports.
Advertisement
Recommended Stories
Analyst adjusts Nvidia stock price target ahead of earnings
This is what could happen next to Nvidia shares.
TheStreetWarren Buffett's Latest $2.6 Billion Buy Brings His Total Investment in This Stock to More Than $77 Billion in Under 6 Years
The Oracle of Omaha has purchased shares of his favorite stock for 23 consecutive quarters.
Motley FoolDon't Sit On Losses: How This Simple Rule Spared Investors From Meta's 77% Crash
The 7% sell rule is one of the tools nimble individual investors have that larger funds which hold large positions among a wide range of stocks may not.
Investor's Business DailyHere's the Income and Net Worth You Need to Reach the Top 50% of American Households
Americans can improve their net worth through prudent budgeting and smart investments.
Motley FoolHere's the Best "Magnificent Seven" Stock to Buy Right Now, According to Wall Street (Hint: Not Nvidia)
Wall Street analysts see significant upside in this red-hot artificial intelligence stock.
Motley FoolBitcoin Drops. Why Almost Everyone Was Wrong About the ‘Halving.’
The halving is a change to Bitcoin’s programmatic monetary policy which cut in half the issuance of new tokens, restricting supply.
Barrons.comMeet the Stock-Split Stock That Makes Up 23% of Billionaire Bill Ackman's $11 Billion Portfolio
Just because a stock pick is obvious doesn't mean it's wrong.
Motley Fool‘Jump on the Bandwagon,’ Says Bank of America About These 2 Stock Picks
This year started with a bang, saw a fizzle in April – but now appears to be regaining its stride. As we saw last year, the gains continue to be dominated by the ‘Magnificent 7’ tech stocks. This group of mega-cap companies collectively experienced a 48% year-over-year earnings increase in the recent first-quarter 2024 releases, in contrast to a 2% collective decline across the other S&P companies. Going forward, however, expectations are that the remaining 493 companies on the S&P will close th
TipRanksForget About ‘Timing the Market': Schwab Research Reveals the Optimal Way to Invest
Can investors realistically time the market to maximize returns, especially over the long term? According to a recent study from Charles Schwab, perfect market timing is practically impossible. The firm’s research showed that most investors are better off investing as soon as possible using a buy-and-hold strategy rather than trying to predict short-term peaks and […] The post Forget About ‘Timing the Market’: Schwab Research Reveals the Optimal Way to Invest appeared first on SmartReads by Smar
SmartAssetWarren Buffett said he could make a 50% return on $1 million and predicted higher taxes. Here are 14 Q&A nuggets.
Warren Buffett teased a potential Canada bet, predicted Berkshire would surpass $200 billion in cash this quarter, and shrugged off dollar worries.
Business Insider